1000-467X
2009 Issue 12
..............page:1323
Synergistic cytotoxicity effect of histone deacetylase inhibitor combined with paclitaxel on lung cancer cell lines and its mechanism
Dong Zhang;1 Chang-Ting Liu;1 Xiao-Dan Yu2 and Yan Liu1 1.Geriatric Respiratory Department;PLA General Hospital;Beijing 100853;P.R.China 2.Institute of Basic Medical Sciences;Academy of Military Medical Science;Beijing 100850;P.R.China
Dong Zhang;1 Chang-Ting Liu;1 Xiao-Dan Yu2 and Yan Liu1 1.Geriatric Respiratory Department;PLA General Hospital;Beijing 100853;P.R.China 2.Institute of Basic Medical Sciences;Academy of Military Medical Science;Beijing 100850;P.R.China
..............page:1270-1276
Expression of TEIF protein in colorectal tumors and its correlation with centrosome abnormality
Ying Gao1;2 and Bo Zhang1 1.Department of Pathology;Health Science Center of Peking University;Beijing;100191;P.R.China 2.Department of Pathology;Beijing Shijitan Hospital;Beijing;100038;P.R.China
Ying Gao1;2 and Bo Zhang1 1.Department of Pathology;Health Science Center of Peking University;Beijing;100191;P.R.China 2.Department of Pathology;Beijing Shijitan Hospital;Beijing;100038;P.R.China
..............page:1277-1282
..............page:1327
Efficacy and survival of 92 cases of Ewing’s sarcoma family of tumor initially treated with multidisciplinary therapy
Rou-Jun Peng;1;2 Xiao-Fei Sun;1;2 Xiao-Juan Xiang1;2;Zi-Jun Zhen;1;2 Jia-Yu Ling;1;2 Gang-Ling Tong;1;2 Yi Xia;1;2 Guang-Chuang Xu1;2 and Wen-Qi Jiang1;2 1.State Key Laboratory of Oncology in South China;Guangzhou;Guangdong;510060;P.R.China 2.Department of Medical Oncology;Sun Yat-sen University Cancer Center;Guangzhou;Guangdong;510060;P.R.China
Rou-Jun Peng;1;2 Xiao-Fei Sun;1;2 Xiao-Juan Xiang1;2;Zi-Jun Zhen;1;2 Jia-Yu Ling;1;2 Gang-Ling Tong;1;2 Yi Xia;1;2 Guang-Chuang Xu1;2 and Wen-Qi Jiang1;2 1.State Key Laboratory of Oncology in South China;Guangzhou;Guangdong;510060;P.R.China 2.Department of Medical Oncology;Sun Yat-sen University Cancer Center;Guangzhou;Guangdong;510060;P.R.China
..............page:1304-1309
Clinical research on recombinant human Ad-p53 injection combined with cisplatin in treatment of malignant pleural effusion induced by lung cancer
Wei-Zhu Zhao;1 Ji-Kun Wang;1 Wei Li1 and Xiu-Li Zhang2 1.Department of Oncology;The First Affiliated Hospital of Liaoning Medical University;Jinzhou;Liaoning;121001;P.R.China 2.Suizhong Hospital;Huludao;Liaoning;125200;P.R.China
Wei-Zhu Zhao;1 Ji-Kun Wang;1 Wei Li1 and Xiu-Li Zhang2 1.Department of Oncology;The First Affiliated Hospital of Liaoning Medical University;Jinzhou;Liaoning;121001;P.R.China 2.Suizhong Hospital;Huludao;Liaoning;125200;P.R.China
..............page:1324-1327
Vascular endothelial growth factor (VEGF)-D in association with VEGF receptor-3 in lymphatic metastasis of breast cancer
Ya-Ning Chen and Yan Gu Department of General Surgery;Shanghai Ninth People’s Hospital;School of Medicine;Shanghai Jiaotong University;Shanghai;200011;P.R.China
Ya-Ning Chen and Yan Gu Department of General Surgery;Shanghai Ninth People’s Hospital;School of Medicine;Shanghai Jiaotong University;Shanghai;200011;P.R.China
..............page:1337-1343
Correlation of hypermethylation of TSP1 gene with TGF-β1 level and T cell immunity in gastric cardia adenocarcinoma
Wei Guo;Zhi-Ming Dong;Yan-Li Guo;Zhi-Bin Yang;Gang Kuang and Bao-En Shan Hebei Cancer Institute;The Fourth Hospital of Hebei Medical University;Shijiazhuang;Hebei;050011;P.R.China
Wei Guo;Zhi-Ming Dong;Yan-Li Guo;Zhi-Bin Yang;Gang Kuang and Bao-En Shan Hebei Cancer Institute;The Fourth Hospital of Hebei Medical University;Shijiazhuang;Hebei;050011;P.R.China
..............page:1298-1303
Germ-line epimutations and human cancer
Pu-Yuan Wu;1;2 Yi-Mei Fan1;2 and Ya-Ping Wang1;2 1. Department of Medical Genetics; Medical School; Nanjing University; Nanjing; Jiangsu 210093; P. R. China 2. Jiangsu Key Laboratory of Molecular Medicine; Nanjing; Jiangsu 210093; P. R. China
Pu-Yuan Wu;1;2 Yi-Mei Fan1;2 and Ya-Ping Wang1;2 1. Department of Medical Genetics; Medical School; Nanjing University; Nanjing; Jiangsu 210093; P. R. China 2. Jiangsu Key Laboratory of Molecular Medicine; Nanjing; Jiangsu 210093; P. R. China
..............page:1236-1242
Clinical characteristics and prognosis of very young patients with breast cancer in the southern of China
Hua Yang;1;2 Si-Yu Wang;1;2 Wei Ou;1;2 Hai-Bo Sun1;2 and Qin Fang1;2 1.State Key Laboratory of Oncology in South China;Guangzhou;Guangdong;510060;P.R.China 2.Department of Thoracic Oncology;Sun Yat-sen University Cancer Center;Guangzhou;Guangdong;510060;P.R.China
Hua Yang;1;2 Si-Yu Wang;1;2 Wei Ou;1;2 Hai-Bo Sun1;2 and Qin Fang1;2 1.State Key Laboratory of Oncology in South China;Guangzhou;Guangdong;510060;P.R.China 2.Department of Thoracic Oncology;Sun Yat-sen University Cancer Center;Guangzhou;Guangdong;510060;P.R.China
..............page:1310-1316
Liquid-based cytology for esophageal carcinoma screening
Hui-Qin Guo;1 Wen-Qiang Wei;2 Ning Lu;1 Jian Cao;1 Zhong-Lin Li;1 Nai-Peng Wang;1 Guo-Qing Wang;3 Qin-jing Pan1 and You-Lin Qiao2 1.Department of Pathology;Cancer Hospital;Chinese Academy of Medical Sciences;Beijing;100021;P.R.China 2.Department of Epidemiology;Cancer Hospital;Chinese Academy of Medical Sciences;Beijing;100021;P.R.China 3.Department of Endoscopy;Cancer Hospital;Chinese Academy of Medical Sciences;Beijing;100021;P.R.China.
Hui-Qin Guo;1 Wen-Qiang Wei;2 Ning Lu;1 Jian Cao;1 Zhong-Lin Li;1 Nai-Peng Wang;1 Guo-Qing Wang;3 Qin-jing Pan1 and You-Lin Qiao2 1.Department of Pathology;Cancer Hospital;Chinese Academy of Medical Sciences;Beijing;100021;P.R.China 2.Department of Epidemiology;Cancer Hospital;Chinese Academy of Medical Sciences;Beijing;100021;P.R.China 3.Department of Endoscopy;Cancer Hospital;Chinese Academy of Medical Sciences;Beijing;100021;P.R.China.
..............page:1243-1247
..............page:1290
Absorption and elimination of photofrin-Ⅱ in human immortalization esophageal epithelial cell line SHEE and its malignant transformation cell line SHEEC
She-Gan Gao;1;2 Li-Dong Wang;1 Xiao-Shan Feng;1;2 Zhi-Feng Qu;2 Tan-You Shan2 and Xuan-Hu Xie2 1.Henan Key Laboratory for Esophageal Cancer;Laboratory for Cancer Research;Basic Medical College;Zhengzhou University;Zhengzhou;Henan;450052;P.R.China 2.Department of Oncology;The First Affiliated Hospital;Cancer Institute;Henan University of Science and Technology;Luoyang;Henan;471003;P.R.China
She-Gan Gao;1;2 Li-Dong Wang;1 Xiao-Shan Feng;1;2 Zhi-Feng Qu;2 Tan-You Shan2 and Xuan-Hu Xie2 1.Henan Key Laboratory for Esophageal Cancer;Laboratory for Cancer Research;Basic Medical College;Zhengzhou University;Zhengzhou;Henan;450052;P.R.China 2.Department of Oncology;The First Affiliated Hospital;Cancer Institute;Henan University of Science and Technology;Luoyang;Henan;471003;P.R.China
..............page:1248-1254
Feasibility and short-term efficacy of simplified intensity-modulated radiotherapy and concurrent chemotherapy for neck and upper thoracic esophageal carcinoma
Wei-Guo Zhu;1;2 Chang-Hua Yu;1;2 Ji-Hua Han;1;2 Tao Li;1;2 Xi-Lei Zhou1;2 and Guang-Zhou Tao1;2 1.Department of Radiation Oncology;Huai’an First People’s Hospital;Huai’an;Jiangsu;223300 2.Huai’an Affiliated Hospital;Nanjing Medical University;Huai’an;Jiangsu;223300
Wei-Guo Zhu;1;2 Chang-Hua Yu;1;2 Ji-Hua Han;1;2 Tao Li;1;2 Xi-Lei Zhou1;2 and Guang-Zhou Tao1;2 1.Department of Radiation Oncology;Huai’an First People’s Hospital;Huai’an;Jiangsu;223300 2.Huai’an Affiliated Hospital;Nanjing Medical University;Huai’an;Jiangsu;223300
..............page:1265-1269
Relationship between tumor necrosis factor β gene polymorphism and acute respiratory distress syndrome after operation for esophageal carcinoma
Li-Xia Liu;Xue-Jian You;Yu-Xiang Zhang;Chai Zhao;Lei Chen and Zhen-Jie Hu Intensive Care Center;The Fourth Hospital of Hebei Medical University;Shijiazhuang;Hebei;050011;P.R.China
Li-Xia Liu;Xue-Jian You;Yu-Xiang Zhang;Chai Zhao;Lei Chen and Zhen-Jie Hu Intensive Care Center;The Fourth Hospital of Hebei Medical University;Shijiazhuang;Hebei;050011;P.R.China
..............page:1255-1259
..............page:1343
Expression of B7-H1 protein in human pancreatic carcinoma tissues and its clinical significance
Xiao-Ling Chen;1;4 Su-Xu Yuan1;Chen Chen2;Yi-Xiang Mao3;Gang Xu2 and Xian-Yuan Wang2 1.Department of Oncology;The First Affiliated Hospital;Soochow University;Suzhou;Jiangsu;215006;P.R.China 2.Department of Pathology;The Second Affiliated Hospital;Zhengzhou University;Zhengzhou;Henan;450014;P.R.China 3.Department of Hepatobiliary and Pancreatic Oncology;Cancer Hospital;Fudan University;Shanghai;200032;P.R.China 4.Department of Oncology;The Shanghai Beizhan Hospital;Shanghai;200070;P.R.China
Xiao-Ling Chen;1;4 Su-Xu Yuan1;Chen Chen2;Yi-Xiang Mao3;Gang Xu2 and Xian-Yuan Wang2 1.Department of Oncology;The First Affiliated Hospital;Soochow University;Suzhou;Jiangsu;215006;P.R.China 2.Department of Pathology;The Second Affiliated Hospital;Zhengzhou University;Zhengzhou;Henan;450014;P.R.China 3.Department of Hepatobiliary and Pancreatic Oncology;Cancer Hospital;Fudan University;Shanghai;200032;P.R.China 4.Department of Oncology;The Shanghai Beizhan Hospital;Shanghai;200070;P.R.China
..............page:1328-1332
Efficacy of cetuximab combined with chemotherapy on advanced colorectal cancer:a report of 53 cases
Gui-Fang Guo;1;2 Liang-Ping Xia;1;2 Bei Zhang;1;2 Wen-Qi Jiang;1;3 Mao-Zhen liu;1;2 Pei-Li Hu;1;2 Xu-Xian Chen;1;2 Hui-Juan Qiu1;2 and Fei-Fei Zhou1;2 1.State Key Laboratory of Oncology in South China;Guangzhou;Guangdong;510060;P.R.China 2.Department of VIP Inpatient Service;Sun Yat-sen University Cancer Center;Guangzhou;Guangdong;510060 P.R.China 3.Department of Medical Oncology;Sun Yat-sen University Cancer Center;Guangzhou;Guangdong;510060 P.R.China
Gui-Fang Guo;1;2 Liang-Ping Xia;1;2 Bei Zhang;1;2 Wen-Qi Jiang;1;3 Mao-Zhen liu;1;2 Pei-Li Hu;1;2 Xu-Xian Chen;1;2 Hui-Juan Qiu1;2 and Fei-Fei Zhou1;2 1.State Key Laboratory of Oncology in South China;Guangzhou;Guangdong;510060;P.R.China 2.Department of VIP Inpatient Service;Sun Yat-sen University Cancer Center;Guangzhou;Guangdong;510060 P.R.China 3.Department of Medical Oncology;Sun Yat-sen University Cancer Center;Guangzhou;Guangdong;510060 P.R.China
..............page:1317-1323
EBV conference establishes goals for defining disease-related EBV subtypes for vaccine development
Laurie Goodman The 2008 International Association for Research on Epstein-Barr virus and Associated Diseases International Epstein-Barr Virus Genome Consortium ; Guangzhou; China Goodman Writing & Editiug; 14 Overbrook Terrace Natic; MA 01760 USA
Laurie Goodman The 2008 International Association for Research on Epstein-Barr virus and Associated Diseases International Epstein-Barr Virus Genome Consortium ; Guangzhou; China Goodman Writing & Editiug; 14 Overbrook Terrace Natic; MA 01760 USA
..............page:1233-1235
LRP16 gene function based on bioinformatic analysis
Bo Yang;1 Xue-Chun Lu;1 Xiao-Hua Chi;2 Wei-Dong Han;3 Li Yu4 and Fang-Ding Lou4 1.Department of Geriatric Hematology;PLA General Hospital;Beijing 100853;P.R.China 2.Department of Pharmacy;262th Hospital of PLA;Beijing 100800;P.R.China 3.Department of Immunology;Institute of Basic Medical Sciences;PLA General Hospital;Beijing 100853;P.R.China 4.Department of Hematology;PLA General Hospital;Beijing 100853;P.R.China
Bo Yang;1 Xue-Chun Lu;1 Xiao-Hua Chi;2 Wei-Dong Han;3 Li Yu4 and Fang-Ding Lou4 1.Department of Geriatric Hematology;PLA General Hospital;Beijing 100853;P.R.China 2.Department of Pharmacy;262th Hospital of PLA;Beijing 100800;P.R.China 3.Department of Immunology;Institute of Basic Medical Sciences;PLA General Hospital;Beijing 100853;P.R.China 4.Department of Hematology;PLA General Hospital;Beijing 100853;P.R.China
..............page:1283-1290
Efficacy of surgical resection of left and right transthoracic approaches for middle thoracic esophageal squamous cell carcinoma
Kong-Jia Luo;1;2 Jian-Hua Fu;1;2 Yi Hu;1;2 Tie-Hua Rong;1;2 Peng Lin;1;2 Xin Wang;1;2 Hong Yang;1;2 Bin Zheng1;2 and Yong-Feng Li1;2 1.State Key Laboratory of Oncology in South China;Guangzhou;Guangdong;510060;P.R.China 2.Department of Thoracic Surgery;Sun Yat-sen University Cancer Center;Guangzhou;Guangdong;510060;P.R.China
Kong-Jia Luo;1;2 Jian-Hua Fu;1;2 Yi Hu;1;2 Tie-Hua Rong;1;2 Peng Lin;1;2 Xin Wang;1;2 Hong Yang;1;2 Bin Zheng1;2 and Yong-Feng Li1;2 1.State Key Laboratory of Oncology in South China;Guangzhou;Guangdong;510060;P.R.China 2.Department of Thoracic Surgery;Sun Yat-sen University Cancer Center;Guangzhou;Guangdong;510060;P.R.China
..............page:1260-1264
Progress on the subcellular localization of Daxx
Su-Fang Chen;Cui-Ming Zhu and Yan-Ping Wan Institute of Pathogenic Biology;University of South China;Hengyang;Hunan;421001;P.R.China
Su-Fang Chen;Cui-Ming Zhu and Yan-Ping Wan Institute of Pathogenic Biology;University of South China;Hengyang;Hunan;421001;P.R.China
..............page:1333-1336
Correlation of the sensitivity of NP chemotherapy in non-small lung cancer with DNA repair gene XRCC1 polymorphism
Cheng-Yu Hong;1;2 Qian Xu;1 Zheng Yue;1 Ye Zhang1 and Yuan Yuan1 1.Cancer Control Laboratory of Cancer Institute and General Surgery Institute;The First Affiliated Hospital of China Medical University;The Key Laboratory of Cancer Control of Liaoning Province;Shenyang;Liaoning;110001;P.R.China 2.Department 4th of Oncology;Tumor Hospital of Liaoning Province;Shenyang;Liaoning;110042;P.R.China
Cheng-Yu Hong;1;2 Qian Xu;1 Zheng Yue;1 Ye Zhang1 and Yuan Yuan1 1.Cancer Control Laboratory of Cancer Institute and General Surgery Institute;The First Affiliated Hospital of China Medical University;The Key Laboratory of Cancer Control of Liaoning Province;Shenyang;Liaoning;110001;P.R.China 2.Department 4th of Oncology;Tumor Hospital of Liaoning Province;Shenyang;Liaoning;110042;P.R.China
..............page:1291-1297